Skip to content
Riskpilot
← Back to search
Sign in
Get full access
CanaDan Bio ApS
APS
Active
Advertising protection
CVR 40896813
Skjulhøj Allé 47, 2720
Vanløse
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2019 · 6 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
CanaDan Bio ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
-1
-2
-1
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-47
-3
-1
-2
-1
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-47
-3
-1
-2
-1
Net financials
33
11
12
7
7
Profit before tax
-14
8
11
4
6
Tax
-3
2
2
1
1
Net profit
-11
6
9
3
4
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
493
676
705
736
773
Equity
5
11
20
24
28
Long-term debt
487
665
0
0
0
Short-term debt
0
0
685
712
745
Total debt
487
665
685
712
745
Financial ratios
5-year trend
EBITDA margin
-139500.0%
This company
15.8%
Market median
-883011% vs market
2021
2025
Equity ratio
3.6%
This company
38.2%
Market median
-91% vs market
2021
2025
Return on equity
15.6%
This company
18.4%
Market median
+15% vs market
2021
2025
Net profit margin
437200.0%
This company
8.1%
Market median
+5397431% vs market
2021
2025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
26.53×
This company
0.62×
Market median
-4179% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on CanaDan Bio ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
